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Human flavin-containing monooxygenase 3 (hFMO3) is a hepatic phase-1 drug metabolising enzyme. 
To date, the tertiary structure of hFMO3 has not been solved and therefore molecular modeling 
attempts have tried to assign a structural/functional role to the predicted secondary structure elements 
of the polypeptide. Here we present a 3D model of this enzyme generated by ab-initio and homology 
modeling using the bacterial FMO structure as template (30% homologous). The model was energy 
minimized and refined.  
Docking experiments were carried out using the DRUGBANK database (3987 molecules). The 
docking output produced putative binding energies for each of the drugs. Known marker substrates of 
hFMO3 such as sulindac, tamoxifen, ranitidine and cimetidine showed binding energies of 8.55, 7.97, 
7.16 and 5.04 Kcal/mol, respectively. As lower binding energies imply a weak interaction while higher 
ones suggest putative inhibitors of the hFMO3, the values here reported give indication of the range 
within which substrates are comprised. This is the first step towards an in vitro screening of new 
chemical entities against hFMO3 for the benefit of pharmaceutical research. 
